Ad
BPTH Quote Trading Chart Bio-Path Holdings Inc.
home / stock / bpth / bpth quote
$4.15 Last:
11.26% Change Percent:
$4.02 Open:
$3.73 Previous Close:
$4.19 High:
$4.02 Low:
4,889 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BPTH Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-15 | 4.02 | 3.73 | 4.19 | 4.02 | 4,889 |
| 2022-08-12 | 4.11 | 3.73 | 4.24 | 4.06 | 42,671 |
| 2022-08-11 | 4.06 | 3.73 | 4.15 | 4 | 17,001 |
| 2022-08-10 | 4.1095 | 3.73 | 4.1095 | 3.97 | 44,736 |
| 2022-08-09 | 4.08 | 3.73 | 4.12 | 3.902 | 23,203 |
| 2022-08-08 | 4.14 | 3.73 | 4.14 | 4 | 21,715 |
| 2022-08-05 | 3.94 | 3.73 | 4.11 | 3.9 | 48,855 |
| 2022-08-04 | 3.672 | 3.73 | 3.9 | 3.65 | 14,927 |
| 2022-08-03 | 3.6912 | 3.73 | 3.83 | 3.6 | 51,539 |
| 2022-08-02 | 3.5 | 3.73 | 3.65 | 3.5 | 35,581 |
| 2022-08-01 | 3.52 | 3.73 | 3.55 | 3.4614 | 17,981 |
| 2022-07-29 | 3.75 | 3.73 | 3.76 | 3.53 | 13,531 |
| 2022-07-28 | 3.73 | 3.73 | 3.7301 | 3.6 | 7,836 |
| 2022-07-26 | 3.69 | 3.69 | 3.7 | 3.58 | 5,267 |
| 2022-07-25 | 3.8671 | 3.69 | 3.97 | 3.65 | 31,653 |
| 2022-07-19 | 4.2 | 3.78 | 4.21 | 3.66 | 100,011 |
| 2022-07-18 | 4.24 | 4.175 | 4.4235 | 4.15 | 14,304 |
| 2022-07-15 | 4.13 | 4.17 | 4.17 | 4.1 | 7,262 |
| 2022-07-14 | 4.2 | 4.07 | 4.2 | 3.6601 | 42,108 |
| 2022-07-13 | 4.15 | 4.22 | 4.2592 | 4.1 | 12,096 |
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
-
HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a...
-
HOUSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial r...
-
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a ...